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ABSTRACT
The relatedness of 112 penicillin-non-susceptible
isolates of Streptococcus pneumoniae from Hungary
was determined by pulsed-field gel electrophor-
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esis (PFGE), serotyping and antibiotic susceptibil-
ity tests. The differences in PFGE patterns closely
mirrored the changes in resistance. Some geno-
types comprised multiple serotypes, and the
genetic diversity among certain serotypes was
considerable. Generally, serotyping alone
was insufficient for epidemiological mapping of
pneumococcal isolates. There was considerable
serotype diversity, but the five most frequent
international serotypes (6, 9, 14, 23, 19) were the
most prevalent. In addition, the presence of some
well-defined resistant international pneumococcal
clones in the Hungarian population was identi-
fied.
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Streptococcus pneumoniae causes a wide range of
serious diseases, and it is essential to determine
the epidemiological and genetic relatedness of
isolates at the local, national and international
levels to control their spread and to develop
new vaccines [1]. Phenotypic and genotypic
typing methods can be used for the character-
isation and epidemiological tracking of these
bacteria. The present study used pulsed-field gel
electrophoresis (PFGE) for molecular characteri-
sation of penicillin-non-susceptible Hungarian
isolates of pneumococci, and then compared
the genotypic PFGE results with phenotypic
results based on serotypes and antibiotic resist-
ance patterns.
Penicillin-non-susceptible, non-invasive S. pneu-
moniae isolates (n = 112), obtained from five
clinical laboratories in Hungary during 2000–
2002 [2], were included in the study. The identi-
ties of all isolates were also confirmed by lytA
PCR [2,3]. Antibiotic susceptibility testing was
performed by the agar dilution method on Mu-
eller–Hinton (Oxoid, Basingstoke, UK) blood agar
plates. The sensitivity and resistance breakpoints
used were, where available, those recommended
by the 2002 NCCLS guidelines [4]. For telithro-
mycin, the following breakpoints were used:
susceptible (S), £ 0.5 mg ⁄L; resistant (R),
‡ 2 mg ⁄L [5,6]. All antibiotics were purchased
from Sigma (Poole, UK), except moxifloxacin
(Bayer, Leverkusen, Germany) and telithromycin
(Aventis Pharma, Bridgewater, NJ, USA).
Serotyping was performed with S. pneumoniae
typing antisera (Mast Group, Bootle, UK). Chro-
mosomal DNA for PFGE was prepared as des-
cribed by Hall et al. [7], with slight modifications.
After digestion with ApaI (Promega, Southamp-
ton, UK), the fragments were separated in a
CHEF-DR II apparatus (Bio-Rad, Hercules, CA,
USA), with pulse times of 2–30 s. The NO34OS k
ladder (New England Biolabs, Hitchin, UK) was
used as a molecular size marker. The PFGE
profiles were analysed with the BioNumerics
program v. 2.5 (Applied Maths, Sint-Martens-
Latem, Belgium). A PFGE genotype was defined
as isolates that showed ‡ 90% identity in the
dendrogram created by the UPGMA ⁄Dice coeffi-
cients with a band position tolerance of 2%, in
accordance with published interpretive criteria
[1]. The presence of the erm and mef macrolide
resistance determinants, when relevant for the
international comparison, was tested by PCR with
the primers described by Sutcliffe et al. [8]. The
mef(E) and mef(A) determinants were distin-
guished with the BamHI restriction method of
Oster et al. [9].
The penicillin MICs for the isolates ranged from
0.125 to 16 mg ⁄L, but there were only eight
penicillin-resistant isolates (MIC ‡ 2 mg ⁄L). The
frequency of macrolide resistance (MIC ‡ 1 mg ⁄L)
was 50–54%. All isolates were sensitive to telithro-
mycin, moxifloxacin, vancomycin and linezolid.
The correlation between the serotypes and
antibiotic susceptibilities of these isolates has
been reported previously [2], but it was important
to establish the genetic stability of individual
serotypes. Although there were 25 different PFGE
genotypes, 70.5% of the isolates belonged to only
five genotypes (Table 1). Twelve genotypes con-
tained only one isolate each. While the other
major genotypes comprised only one serogroup,
the two largest genotypes, A and B, comprised
two serogroups each (9 ⁄ 14 and 6A ⁄ 23F, respect-
ively), and the isolates were clearly sub-clustered
according to the serotypes. Additionally, there
was a close correlation between the genotypes
and the penicillin and macrolide susceptibility
levels.
Pneumococcal isolates from Hungary have
rarely been serotyped routinely. Instead of the
previously reported predominance of serotype
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19A (39.2% of a total of 51 isolates) [10], a
considerable diversity in serotypes was observed
in the present study, with 92.9% of the isolates
belonging to the five major international resist-
ant serogroups 6, 9, 23, 14 and 19 (Table 2),
although serogroups ⁄ types 15, 7, 11, 18 and 35
were also present. Serotype 19A represented
only 6.5% of all isolates, but six of the isolates
in this serogroup had high-level penicillin resist-
ance (MIC 4–16 mg ⁄L) and belonged to the
same PFGE genotype C. On the other hand,
isolates of serotype 19F had low penicillin MICs
(£ 0.25 mg ⁄L). There were also 12 additional
penicillin-sensitive isolates belonging to sero-
group 19.
The genetic diversity within serogroups 6 and 19
(almost all macrolide-resistant) was high, while
serogroups 9 and 23 (predominantly macrolide-
susceptible, but with higher penicillin MICs)
appeared to be mostly clonal (Table 2). This sug-
gests that decreased penicillin susceptibility is
spreading clonally. In contrast, genetic diversity
within macrolide-resistant isolates is much higher,
probably because of the frequent horizontal trans-
fer of the erm or mef genes to isolates with different
genetic backgrounds [11]. Other studies have
reported the same difference in clonality [12], but
hypothesised that the resistant clones of serotype
6B emerged earlier in the antibiotic era, and hence
could become more diverse than the relatively
newer clones of serotypes 9V and 23F. However,
this hypothesis depends on the genetic stability of
the serotype, which is contraindicated by the
results of the present study.
In general, the differences in the PFGE pattern
correlated well with the phenotypic changes
among the genotypes, but isolates with an iden-
tical serotype could belong to several unrelated
genotypes. These findings support the suggestion
that serotyping may not accurately categorise
isolates, and that isolates may better be analysed
by the use of genotyping as the primary screen
[13–15].
Five of the 16 Pneumococcal Molecular Epi-
demiology Network (PMEN) international clones
[13] were found among the Hungarian isolates
when their PFGE patterns were compared, pro-
viding further evidence for the successful spread
of certain pneumococcal clones across Europe.
Notably there was an exact match between the
Hungary19A-6 PMEN clone and genotype C in the
present study, with high-level penicillin and
macrolide resistance, suggesting that this geno-
type has been circulating in the country for at
least 20 years. Further identity or very close
similarity was observed between the Spain9V-3
and Spain23F-1 PMEN clones and members of two
prevalent Hungarian genotypes. Among the
macrolide-resistant isolates, identity was found
with the Taiwan19F-14 and the England14-9 PMEN
clones, and the isolates in the present study also
carried the mef(E) and mef(A) resistance determi-
nants, respectively. In all cases, the sero-
types ⁄ groups and the antibiotic susceptibility
patterns of the Hungarian isolates were the same
as those of the PMEN clones. However, to confirm
the results of this international comparison,
Table 1. Serogroups and antibiotic sensitivities of 112
penicillin-non-susceptible pneumococcal isolates, grouped
by the prevalence of their pulsed-field gel electrophoresis
(PFGE) genotypes
PFGE
genotype
No. of
isolates
Serogroup
(no. of isolates)
Penicillin
Clarithro-
mycin
I R S R
A 32 9 (19), 14 (13) 31 1 25 7
B 25 6A (13), 23F (12) 25 0 13 12
J 11 6 (11) 10 1 0 11
C 6 19A (6) 0 6 0 6
A2 5 9 (5) 5 0 0 5
K 3 6 (3) 3 0 0 3
G 3 19F (3) 3 0 0 3
O 3 15 (3) 3 0 0 3
B2 3 23 (3) 3 0 3 0
JA 3 6 (3) 3 0 0 3
M 2 23 (2) 2 0 2 0
X 2 6 (2) 2 0 0 2
CS 2 19 (2) 2 0 1 1
Othersa 12
aThis category includes 12 genotypes, each containing one isolate (of different
serotypes).
R, resistant; I, intermediately resistant; S, susceptible.
Table 2. Pulsed-field gel electrophoresis (PFGE) geno-
types and antibiotic susceptibilities of 112 penicillin-
non-susceptible pneumococcal isolates, grouped by the
prevalence of their serogroups
Serogroup
No. of
isolates
PFGE genotype
(no. of isolates)
Penicillin
Clarith-
romycin
I R S R
6 37 J (11), B (13), K (3), JA (3),
X (2), + 5 other (1 each)
36 1 4 33
9 24 A (19), A2 (5) 24 0 18 6
23 18 B (12), B2 (3), M (2), D (1) 18 0 17 1
14 14 A(13), E(1) 13 1 7 7
19 11 C (6), G (3), CS (2) 5 6 1 10
15 4 O (3), R (1) 4 0 3 1
Othersa 4
aSerogroups 7, 11, 18 and 35 were represented by one isolate each (different
genotypes).
R, resistant; I, intermediately resistant; S, susceptible.
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multilocus sequence typing of the isolates would
be required.
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ABSTRACT
In total, 320 vaginal or rectal swabs were cultured
on Granada medium (GM) or Group B Streptococ-
cus Differential Agar (GBSDA), and were also
inoculated into LIM broth (Todd–Hewitt broth
supplemented with selective antibiotics), for
detection of group B Streptococcus (GBS). Overall,
GBS isolates were detected on 53 of the 320 swabs;
47 of these isolates grew on both GM and GBSDA,
five only on GBSDA, and one only following
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